Loading...
OTCM
ECIA
Market cap18kUSD
Jun 15, Last price  
0.00USD
Name

Encision Inc

Chart & Performance

D1W1MN
OTCM:ECIA chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
4.82%
Rev. gr., 5y
-5.16%
Revenues
6m
-11.76%
11,010,03812,065,65912,789,29312,836,00011,616,65712,988,65011,767,00010,546,6379,671,0009,336,0008,870,0008,754,0008,802,4567,670,0007,538,0007,668,0007,349,0006,585,8826,555,3155,784,191
Net income
-719k
L+226.56%
-90,077-179,318159,817265,0004,564-530,653-616,000-1,781,678-1,383,000-880,000-729,000336,000-236,096-241,430584,734463,340-366,000-691,783-220,198-719,080
CFO
-384k
L+599.61%
-116,959-467,213694,837466,286196,174159,635-315,793111,206-1,432,771-165,83823,000420,000-127,242-229,000220,000-444,000-861,000144,389-54,948-384,422

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.
IPO date
Jun 25, 1996
Employees
31
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT